Conversely, loss of Nrf1’s function by gene-targeting in mice leads to severe oxidative stress and spontaneous development of distinct pathological phenotypes, resembling human non-alcoholic steatohepatitis (NASH) with progressive hepatoma, neurodegenerative diseases or diabetes mellitus (3). The gene discussed is NRF1; the disease is metabolic dysfunction-associated steatohepatitis.